EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysis

Nicolaus Mussmaecher, Steffen Mitzner, Christian Haas, Martin Busch, Markus Ketteler, Christoph Wanner, Patrick Biggar

Clinical Nephrology · 2026

DOI: 10.5414/cn111768 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Nephrology, 2026. Verfasst von Nicolaus Mussmaecher und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Ergocalciferols, Fibroblast Growth Factors, Renal Dialysis, Parathyroid Hormone.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErgocalciferolsFibroblast Growth FactorsRenal DialysisParathyroid HormoneKidney Failure, ChronicHyperparathyroidism, SecondaryBone Density Conservation AgentsHumansFibroblast Growth Factor-23FemaleMiddle AgedMaleCross-Over StudiesDouble-Blind MethodAgedProspective StudiesDose-Response Relationship, DrugBiomarkers

Substanzen

Fibroblast Growth Factor-23paricalcitolFGF23 protein, humanErgocalciferolsFibroblast Growth FactorsParathyroid HormoneBone Density Conservation AgentsBiomarkers

Zitieren

APA

Mussmaecher, N., Mitzner, S., Haas, C., Busch, M., Ketteler, M., Wanner, C., & Biggar, P. (2026). Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysis. Clinical Nephrology. https://doi.org/10.5414/cn111768

Vancouver

Mussmaecher N, Mitzner S, Haas C, Busch M, Ketteler M, Wanner C, et al. Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysis. Clinical Nephrology. 2026. doi:10.5414/cn111768

BibTeX
@article{Mussmaecher2026,
  author = {Mussmaecher, Nicolaus and Mitzner, Steffen and Haas, Christian and Busch, Martin and Ketteler, Markus and Wanner, Christoph and Biggar, Patrick},
  title = {Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysis},
  journal = {Clinical Nephrology},
  year = {2026},
  doi = {10.5414/cn111768}
}
Kostenlos starten →